A microscale HPLC-UV method for the determination of latamoxef in plasma: An adapted method for therapeutic drug monitoring in neonates-Reference-Cited by-同舟云学术

A microscale HPLC-UV method for the determination of latamoxef in plasma: An adapted method for therapeutic drug monitoring in neonates

Published:2018-04-17 Issue:8 Volume:32 Page:e4243
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Dong Qian¹,Shi Hai-Yan¹²,Kou Chen³,Huang Xin²,Shen A-Dong⁴,Zhao Wei¹²^ORCID

Affiliation:

1. Department of Clinical Pharmacy, School of Pharmaceutical Sciences; Shandong University; Jinan China

2. Department of Pharmacy, Shandong Provincial Qianfoshan Hospital; Shandong University; Jinan China

3. Department of Neonatology, Beijing Obstetrics and Gynecology Hospital; Capital Medical University; Beijing China

4. Key Laboratory of Major Diseases in Children and National Key Discipline of Pediatrics (Capital Medical University), Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital; Capital Medical University; Beijing China

Funder

Major New Drugs Innovation and Development

Young Scholars Program of Shandong University

Young Taishan Scholars Program

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Reference13 articles.

1. Determination of moxalactam by high-performance liquid chromatography;Aravind;Journal of Chromatography B: Biomedical Sciences & Applications,1982

2. Moxalactam (latamoxef);Carmine;Drugs,1983

3. CLSI supplement M100S;Clinical And Laboratory Standards Institute,2016